The goal of this clinical trial is to assess the feasibility and safety of oral nicotinamide (NAM; a derivative of vitamin B3 \[niacin\]) and vitamin A in a hi…

Skin CancerKidney Transplant Recipients

~Estimated

~$10 – $6,250

Rhode Island HospitalNCT05702398

Phase 4

A Pilot Trial of the Tolerability and Clinical Effectiveness of Letermovir When Used for Secondary Prophylaxis to Prevent Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients

This is a research study to test the tolerability and clinical effectiveness of the study drug, Letermovir (LET), when used as secondary prophylaxis following …

Cytomegalovirus InfectionsInfection in Solid Organ Transplant RecipientsNeutropenia+1 more

~Estimated

~$10 – $6,250

Tufts Medical CenterNCT05626530

Phase 2

A Phase 2 Study of Fludarabine and Intermediate-dose Total Body Irradiation (800 cGy) Followed by Post-transplant Cyclophosphamide in Patients Aged 18-65 Undergoing Allogeneic Stem Cell Transplant for Hematologic Malignancies

The Flu-TBI 800 trial is a prospective, single-arm, multicenter, interventional phase 2 study to evaluate whether fludarabine plus intermediate-dose total body…

Allogeneic Stem Cell Transplant Recipient

~Estimated

~$10 – $7,500

Hackensack Meridian HealthNCT07214688

← PreviousPage 2 of 2Next →